APO Research
Talk to an analyst

APO RESEARCH · REPORT

Everolimus Eluting Stent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Everolimus Eluting Stent Market Outlook and Growth Opportunities 2026

25 December 2025198 pages

Choose your research edition.

Industry ResearchEverolimus Eluting Stent Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Everolimus Eluting Stent Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Everolimus Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Everolimus Eluting Stent Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Everolimus Eluting Stent Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Everolimus Eluting Stent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Everolimus Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Everolimus Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Everolimus Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Everolimus Eluting Stent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Everolimus Eluting Stent market include Boston Scientific and Abbott among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Everolimus Eluting Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Everolimus Eluting Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Everolimus Eluting Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Everolimus Eluting Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Everolimus Eluting Stent Segment by Company

Boston Scientific

Abbott

Everolimus Eluting Stent Segment by Type

PLGA Polymer Coating

Fluoropolymer Coating

Everolimus Eluting Stent Segment by Application

Hospital

Clinic

Others

Everolimus Eluting Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Everolimus Eluting Stent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Everolimus Eluting Stent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Everolimus Eluting Stent significant trends, drivers, influence factors in global and regions.

6. To analyze Everolimus Eluting Stent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Everolimus Eluting Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Everolimus Eluting Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Everolimus Eluting Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Everolimus Eluting Stent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Everolimus Eluting Stent industry.

Chapter 3: Detailed analysis of Everolimus Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Everolimus Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Everolimus Eluting Stent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Everolimus Eluting Stent Industry Trends Table 2. Everolimus Eluting Stent Industry Drivers Table 3. Everolimus Eluting Stent Industry Opportunities and Challenges Table 4. Everolimus Eluting Stent Industry Restraints Table 5. Global Everolimus Eluting Stent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Everolimus Eluting Stent Revenue Share by Company (2021-2026) Table 7. Global Everolimus Eluting Stent Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Everolimus Eluting Stent Sales Volume Share by Company (2021-2026) Table 9. Global Everolimus Eluting Stent Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Everolimus Eluting Stent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Everolimus Eluting Stent Key Company Manufacturing Base & Headquarters Table 12. Global Everolimus Eluting Stent Company, Product Type & Application Table 13. Global Everolimus Eluting Stent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Everolimus Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PLGA Polymer Coating Table 18. Significant Companies of Fluoropolymer Coating Table 19. Global Everolimus Eluting Stent Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Everolimus Eluting Stent Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Everolimus Eluting Stent Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Everolimus Eluting Stent Sales Volume Share by Type (2021-2026) Table 23. Global Everolimus Eluting Stent Sales Volume Share by Type (2027-2032) Table 24. Global Everolimus Eluting Stent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Everolimus Eluting Stent Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Everolimus Eluting Stent Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Everolimus Eluting Stent Sales Value Share by Type (2021-2026) Table 28. Global Everolimus Eluting Stent Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Everolimus Eluting Stent Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Everolimus Eluting Stent Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Everolimus Eluting Stent Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Everolimus Eluting Stent Sales Volume Share by Application (2021-2026) Table 36. Global Everolimus Eluting Stent Sales Volume Share by Application (2027-2032) Table 37. Global Everolimus Eluting Stent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Everolimus Eluting Stent Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Everolimus Eluting Stent Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Everolimus Eluting Stent Sales Value Share by Application (2021-2026) Table 41. Global Everolimus Eluting Stent Sales Value Share by Application (2027-2032) Table 42. Global Everolimus Eluting Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Everolimus Eluting Stent Sales by Region (2021-2026) & (K Units) Table 44. Global Everolimus Eluting Stent Sales Market Share by Region (2021-2026) Table 45. Global Everolimus Eluting Stent Sales by Region (2027-2032) & (K Units) Table 46. Global Everolimus Eluting Stent Sales Market Share by Region (2027-2032) Table 47. Global Everolimus Eluting Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Everolimus Eluting Stent Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Everolimus Eluting Stent Sales Value Share by Region (2021-2026) Table 50. Global Everolimus Eluting Stent Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Everolimus Eluting Stent Sales Value Share by Region (2027-2032) Table 52. Global Everolimus Eluting Stent Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Everolimus Eluting Stent Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Everolimus Eluting Stent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Everolimus Eluting Stent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Everolimus Eluting Stent Sales by Country (2021-2026) & (K Units) Table 57. Global Everolimus Eluting Stent Sales Market Share by Country (2021-2026) Table 58. Global Everolimus Eluting Stent Sales by Country (2027-2032) & (K Units) Table 59. Global Everolimus Eluting Stent Sales Market Share by Country (2027-2032) Table 60. Global Everolimus Eluting Stent Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Everolimus Eluting Stent Sales Value Market Share by Country (2021-2026) Table 62. Global Everolimus Eluting Stent Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Everolimus Eluting Stent Sales Value Market Share by Country (2027-2032) Table 64. Boston Scientific Company Information Table 65. Boston Scientific Business Overview Table 66. Boston Scientific Everolimus Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Boston Scientific Everolimus Eluting Stent Product Portfolio Table 68. Boston Scientific Recent Development Table 69. Abbott Company Information Table 70. Abbott Business Overview Table 71. Abbott Everolimus Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Abbott Everolimus Eluting Stent Product Portfolio Table 73. Abbott Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Everolimus Eluting Stent Distributors List Table 77. Everolimus Eluting Stent Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Everolimus Eluting Stent Product Image Figure 2. Global Everolimus Eluting Stent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Everolimus Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Everolimus Eluting Stent Sales (2021-2032) & (K Units) Figure 5. Global Everolimus Eluting Stent Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Everolimus Eluting Stent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PLGA Polymer Coating Image Figure 10. Fluoropolymer Coating Image Figure 11. Global Everolimus Eluting Stent Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Everolimus Eluting Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Everolimus Eluting Stent Sales Volume Share by Type (2021-2032) Figure 14. Global Everolimus Eluting Stent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Everolimus Eluting Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Everolimus Eluting Stent Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Everolimus Eluting Stent Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Everolimus Eluting Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Everolimus Eluting Stent Sales Volume Share by Application (2021-2032) Figure 23. Global Everolimus Eluting Stent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Everolimus Eluting Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Everolimus Eluting Stent Sales Value Share by Application (2021-2032) Figure 26. Global Everolimus Eluting Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Everolimus Eluting Stent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Everolimus Eluting Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Everolimus Eluting Stent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Everolimus Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 31. North America Everolimus Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Everolimus Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Everolimus Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Everolimus Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Everolimus Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Everolimus Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 37. South America Everolimus Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Everolimus Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Everolimus Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Everolimus Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Everolimus Eluting Stent Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Everolimus Eluting Stent Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • PLGA Polymer Coating
  • Fluoropolymer Coating
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boston Scientific
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Everolimus Eluting Stent Sales Value (2021-2032)
  4. 1.2.2 Global Everolimus Eluting Stent Sales Volume (2021-2032)
  5. 1.2.3 Global Everolimus Eluting Stent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Everolimus Eluting Stent Market Dynamics
  1. 2.1 Everolimus Eluting Stent Industry Trends
  2. 2.2 Everolimus Eluting Stent Industry Drivers
  3. 2.3 Everolimus Eluting Stent Industry Opportunities and Challenges
  4. 2.4 Everolimus Eluting Stent Industry Restraints
3 Everolimus Eluting Stent Market by Company
  1. 3.1 Global Everolimus Eluting Stent Company Revenue Ranking in 2025
  2. 3.2 Global Everolimus Eluting Stent Revenue by Company (2021-2026)
  3. 3.3 Global Everolimus Eluting Stent Sales Volume by Company (2021-2026)
  4. 3.4 Global Everolimus Eluting Stent Average Price by Company (2021-2026)
  5. 3.5 Global Everolimus Eluting Stent Company Ranking (2024-2026)
  6. 3.6 Global Everolimus Eluting Stent Company Manufacturing Base and Headquarters
  7. 3.7 Global Everolimus Eluting Stent Company Product Type and Application
  8. 3.8 Global Everolimus Eluting Stent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Everolimus Eluting Stent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Everolimus Eluting Stent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Everolimus Eluting Stent Market by Type
  1. 4.1 Everolimus Eluting Stent Type Introduction
  2. 4.1.1 PLGA Polymer Coating
  3. 4.1.2 Fluoropolymer Coating
  4. 4.2 Global Everolimus Eluting Stent Sales Volume by Type
  5. 4.2.1 Global Everolimus Eluting Stent Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Everolimus Eluting Stent Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Everolimus Eluting Stent Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Everolimus Eluting Stent Sales Value by Type
  9. 4.3.1 Global Everolimus Eluting Stent Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Everolimus Eluting Stent Sales Value by Type (2021-2032)
  11. 4.3.3 Global Everolimus Eluting Stent Sales Value Share by Type (2021-2032)
5 Everolimus Eluting Stent Market by Application
  1. 5.1 Everolimus Eluting Stent Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Everolimus Eluting Stent Sales Volume by Application
  6. 5.2.1 Global Everolimus Eluting Stent Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Everolimus Eluting Stent Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Everolimus Eluting Stent Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Everolimus Eluting Stent Sales Value by Application
  10. 5.3.1 Global Everolimus Eluting Stent Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Everolimus Eluting Stent Sales Value by Application (2021-2032)
  12. 5.3.3 Global Everolimus Eluting Stent Sales Value Share by Application (2021-2032)
6 Everolimus Eluting Stent Regional Sales and Value Analysis
  1. 6.1 Global Everolimus Eluting Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Everolimus Eluting Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Everolimus Eluting Stent Sales by Region: 2021-2026
  4. 6.2.2 Global Everolimus Eluting Stent Sales by Region (2027-2032)
  5. 6.3 Global Everolimus Eluting Stent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Everolimus Eluting Stent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Everolimus Eluting Stent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Everolimus Eluting Stent Sales Value by Region (2027-2032)
  9. 6.5 Global Everolimus Eluting Stent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Everolimus Eluting Stent Sales Value (2021-2032)
  12. 6.6.2 North America Everolimus Eluting Stent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Everolimus Eluting Stent Sales Value (2021-2032)
  15. 6.7.2 Europe Everolimus Eluting Stent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Everolimus Eluting Stent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Everolimus Eluting Stent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Everolimus Eluting Stent Sales Value (2021-2032)
  21. 6.9.2 South America Everolimus Eluting Stent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Everolimus Eluting Stent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Everolimus Eluting Stent Sales Value Share by Country, 2025 VS 2032
7 Everolimus Eluting Stent Country-level Sales and Value Analysis
  1. 7.1 Global Everolimus Eluting Stent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Everolimus Eluting Stent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Everolimus Eluting Stent Sales by Country (2021-2032)
  4. 7.3.1 Global Everolimus Eluting Stent Sales by Country (2021-2026)
  5. 7.3.2 Global Everolimus Eluting Stent Sales by Country (2027-2032)
  6. 7.4 Global Everolimus Eluting Stent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Everolimus Eluting Stent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Everolimus Eluting Stent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Everolimus Eluting Stent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Everolimus Eluting Stent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Everolimus Eluting Stent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boston Scientific
  2. 8.1.1 Boston Scientific Company Information
  3. 8.1.2 Boston Scientific Business Overview
  4. 8.1.3 Boston Scientific Everolimus Eluting Stent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boston Scientific Everolimus Eluting Stent Product Portfolio
  6. 8.1.5 Boston Scientific Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Everolimus Eluting Stent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Everolimus Eluting Stent Product Portfolio
  12. 8.2.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Everolimus Eluting Stent Value Chain Analysis
  2. 9.1.1 Everolimus Eluting Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Everolimus Eluting Stent Sales Mode & Process
  6. 9.2 Everolimus Eluting Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Everolimus Eluting Stent Distributors
  9. 9.2.3 Everolimus Eluting Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst